Ultimately, the goal is to empower the automotive industry with smarter, more efficient technology. By focusing on full-stack innovation, supply chain agility, and specific niche excellence, ...

New AAV therapy for retinitis pigmentosa completes Phase I/II dosing, aiming to protect cones and slow vision loss; first ...

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ...

To move AI projects from pilots and plans to full implementation, organizations must adopt a structured, strategic approach.

Google’s DORA first report on AI coding maturity provides a valuable starting point and a bevy of helpful metrics. It also ...

In this exclusive interview with Daily Trust, the president of the Nigerian Cancer Society, Abidemi Omonisi, offers an assessment of cancer situation in the country. He discusses government ...

This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...

One of the most widely used safety requirements in working environments, laboratories, workshops, and factories is eye ...

Today, everyone connected to the AI industry is talking about physical AI. The term has rapidly moved from niche discussions into the mainstream agenda. Illustrative example: NVIDIA has placed ...

Sports-related ocular injuries represent a significant percentage of ocular trauma cases.With the growing number of people participating in sports and recreational physical activities, the incidence ...

The E-Commerce & Digital Marketing Association (ECDMA) announces the admission of Aleksei Sovetkin to its Senior Member tier, ...

Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...